3 Medical Devices Stocks to Sell Now

GIVN, GB, TRNX slump in weekly rankings

   
3 Medical Devices Stocks to Sell Now

This week, the overall grades of three Medical Devices stocks are lower, according to the Portfolio Grader database. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

This week, Given Imaging (NASDAQ:GIVN) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Given Imaging has developed a proprietary wireless imaging system that allows a medical professional to examine the gastrointestinal tract. In Portfolio Grader’s specific subcategory of Earnings Surprise, GIVN also gets an F. The stock price has fallen 5.9% over the past month, worse than the 1.3% decrease the Nasdaq has seen over the same period of time. The stock currently has a trailing PE Ratio of 31.80. For a full analysis of GIVN stock, visit Portfolio Grader.

Greatbatch (NYSE:GB) earns a D this week, moving down from last week’s grade of C. Greatbatch develops and manufactures power sources, feedthroughs, and wet tantalum capacitors used in implantable medical devices. The stock gets F’s in Earnings Growth, Earnings Momentum, and Margin Growth. To get an in-depth look at GB, get Portfolio Grader’s complete analysis of GB stock.

Tornier (NASDAQ:TRNX) earns an F (“strong sell”) this week, moving down from last week’s grade of D (“sell”). Tornier designs, outsources the manufacture of and markets orthopedic products. The stock gets F’s in Earnings Momentum and Earnings Revisions. For more information, get Portfolio Grader’s complete analysis of TRNX stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, http://investorplace.com/2013/07/3-medical-devices-stocks-to-sell-now-givn-gb-trnx-18/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.